Your browser doesn't support javascript.
loading
Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis.
Coustal, Cyrille; Du Thanh, Aurélie; Roubille, François; Assenat, Eric; Maria, Alexandre T J.
Afiliación
  • Coustal C; Department of Internal Medicine, Multi-Organic Diseases, Local Referral Center for Rare Auto-immune Diseases, Montpellier University Hospital, Montpellier, France.
  • Du Thanh A; Department of Dermatology, Montpellier University Hospital, Montpellier, France.
  • Roubille F; Department of Cardiology, Montpellier University Hospital, Montpellier, France.
  • Assenat E; Department of Oncology, Saint Eloi Hospital, Montpellier University Hospital, Montpellier, France.
  • Maria ATJ; Department of Internal Medicine, Multi-Organic Diseases, Local Referral Center for Rare Auto-immune Diseases, Montpellier University Hospital, Montpellier, France; Institute of Regenerative Medicine and Biotherapy, Institut national de la santé et de la recherche médicale U1183, Montpellier, France.
Eur J Cancer ; 155: 25-27, 2021 09.
Article en En | MEDLINE | ID: mdl-34332401
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Dermatomiositis / Inhibidores de Puntos de Control Inmunológico / Anticuerpos Monoclonales Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Dermatomiositis / Inhibidores de Puntos de Control Inmunológico / Anticuerpos Monoclonales Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article